Table 7. Complications following heparin-induced thrombocytopenia in patients on extracorporeal life support (ECLS).

Variable	VA-ECMO (n=15)	VV-ECMO (n=13)	Total (n=28)	P value
Bleeding, n (%)	2 (13.3)	4 (30.8)	6 (21.4)	0.509
Total thrombosis, n (%)	10 (66.7)	5 (38.5)	15 (53.6)	0.266
Thromboembolism, n (%)
Arterial	8 (53.3)	0 (0.0)	8 (28.6)	0.007
Ischemic cerebrovascular accident	2 (13.3)	0 (0.0)	2 (7.1)	0.528
Digital ischemia	2 (13.3)	0 (0.0)	2 (7.1)	0.528
Upper limb ischemia leading to amputation	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Axillary artery thrombosis	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Femoral artery thrombosis	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Aortic valve thrombosis	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Venous	5 (33.3)	1 (7.7)	6 (21.4)	0.235
Deep vein thrombosis, lower limbs	0 (0.0)	1 (7.7)	1 (3.6)	0.942
Deep vein thrombosis, unspecified	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Upper limb, unspecified	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Femoral vein thrombosis	1 (6.7)	0 (0.0)	1 (3.6)	1.000
Inferior vena cava thrombosis	1 (6.7)	0 (0.0)	1 (3.6)	1.000
ECLS circuit	2 (13.3)	4 (30.8)	6 (21.4)	0.509
Oxygenator	0 (0.0)	4 (30.8)	4 (14.3)	0.075
Unspecified	2 (13.3)	0 (0.0)	2 (7.1)	0.528
ECLS device/circuit exchange, n (%)	2 (13.3)	7 (53.8)	9 (32.1)	0.060

VA, veno-arterial; VV, veno-venous; ECMO, extracorporeal membrane oxygenation; ECLS, extracorporeal life support.